Troscan 100 mg film coated tablet for Dogs

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Nitroscanate

Available from:

Chanelle Animal Health Ltd.

ATC code:

QP52AX01

INN (International Name):

Nitroscanate

Dosage:

100 mg/tablet

Pharmaceutical form:

Film-coated tablet

Prescription type:

CAM: Companion Animal Medicine as defined in relevant national legislation

Therapeutic group:

Dogs

Therapeutic area:

nitroscanate

Therapeutic indications:

Endoparasiticide

Authorization status:

Authorised

Authorization date:

1994-02-10

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Troscan 100 mg film coated tablet for Dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
EACH TABLET CONTAINS
ACTIVE SUBSTANCE:
Nitroscanate
100 mg
EXCIPIENT(S):
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Film coated tablet.
Yellow film coated round convex tablet.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is a broad spectrum anthelmintic for use in puppies and
adult dogs for the treatment of infection by adult
intestinal nematodes or cestodes of the following species:
Nematodes:_ Toxocara canis, Toxascaris leonina, Ancylostoma caninum,
Uncinaria stenocephala_
Cestodes:_ Taenia hydatigena, Taenia pisiformis, Dipylidium caninum_
4.3 CONTRAINDICATIONS
Do not administer to sick or convalescing animals.
Do not use in puppies of less than 3 weeks of age.
Do not use in cases of hepatic dysfunction.
Do not use in cases of known hypersensitivity to the active substance.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The product is not indicated for the treatment of_ Trichuris vulpis_
and gives only a limited level of control of
_Echinococcus granulosus._
Since the most common tapeworm of the dog (_Dipylidium caninum_) is
transmitted by a flea and has a very short pre-
patent period, it is important to pay attention to flea control to
reduce the incidence of tapeworm in the animal.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_